E-LIB Suche - Ergebnisse für: Supko, Jeffrey

1

DDDR-17. CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAP..:

Mayr, Lisa ; Trissal, Maria ; Schwark, Kallen...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v108-v109 , 2023

Link: https://doi.org/10.1093/..

2

HGG-19. CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPR..:

Trissal, Maria ; Mayr, Lisa ; Schwark, Kallen...
Neuro-Oncology. 25 (2023) Supplement_1 - p. i43-i44 , 2023

Link: https://doi.org/10.1093/..

3

DDDR-22. TRANSLATION OF THE PDGFRA/KIT INHIBITOR AVAPRITINI..:

Mayr, Lisa ; Trissal, Maria ; Schwark, Kallen...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii103-vii103 , 2022

Link: https://doi.org/10.1093/..

4

Baseline requirements for novel agents being considered for..:

Grossman, Stuart A ; Romo, Carlos G ; Rudek, Michelle A...
Neuro-Oncology. 22 (2020) 10 - p. 1422-1424 , 2020

Link: https://doi.org/10.1093/..

5

ACTR-58. BASELINE REQUIREMENTS FOR NOVEL AGENTS BEING CONSI..:

Grossman, Stuart ; Romo, Carlos ; Rudek-Renaut, Michelle...
Neuro-Oncology. 21 (2019) Supplement_6 - p. vi27-vi27 , 2019

Link: https://doi.org/10.1093/..

6

ACTR-14. PHASE I STUDY OF AZD1775 WITH RADIATION THERAPY (R..:

Alexander, Brian ; Supko, Jeffrey ; Agar, Nathalie...
Neuro-Oncology. 20 (2018) suppl_6 - p. vi13-vi14 , 2018

Link: https://doi.org/10.1093/..

7

Identification of a Benzoisoxazoloazepine Inhibitor (CPI-06..:

Albrecht, Brian K. ; Gehling, Victor S. ; Hewitt, Michael C....
Journal of Medicinal Chemistry. 59 (2016) 4 - p. 1330-1339 , 2016

Link: https://doi.org/10.1021/..

8

P-348 A phase I trial of gemcitabine followed by flavopirid..:

Goffin, John ; Appleman, Leonard ; Ryan, David...
Lung Cancer. 41 (2003) - p. S179-S180 , 2003

Link: https://doi.org/10.1016/..

9

Pharmacokinetics of ecteinascidin 743 administered as a 24-..:

Puchalski, Thomas ; Ryan, David ; Garcia-Carbonero, Rocio...
Cancer Chemotherapy and Pharmacology. 50 (2002) 4 - p. 309-319 , 2002

Link: https://doi.org/10.1007/..

10

Plasma pharmacokinetics and bioavailability of 1-(2-chloroe..:

Supko, Jeffrey ; Garcia-Carbonero, Rocio ; Puchalski, Thomas.
Cancer Chemotherapy and Pharmacology. 48 (2001) 3 - p. 202-208 , 2001

Link: https://doi.org/10.1007/..

11

Cytotoxic chemotherapy: Advances in delivery, pharmacology,..:

Ciordia, Roberto ; Supko, Jeffrey ; Gatineau, Michel.
Current Oncology Reports. 2 (2000) 5 - p. 445-453 , 2000

Link: https://doi.org/10.1007/..

12

A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule ..:

Blum, Kristie A. ; Supko, Jeffrey G. ; Maris, Michael B....
Cancer Research Communications. 2 (2022) 8 - p. 795-805 , 2022

Link: https://doi.org/10.1158/..

13

Targeting constitutively active STAT3 in chronic lymphocyti..:

Brown, Jennifer R. ; Walker, Sarah R. ; Heppler, Lisa N....
American Journal of Hematology. 96 (2021) 4 - p. , 2021

Link: https://doi.org/10.1002/..

14

Multimodal platform for assessing drug distribution and res..:

Lopez, Begoña G C ; Kohale, Ishwar N ; Du, Ziming...
Neuro-Oncology. 24 (2021) 1 - p. 64-77 , 2021

Link: https://doi.org/10.1093/..

15

Combined PARP and HSP90 inhibition: preclinical and Phase 1..:

Konstantinopoulos, Panagiotis A. ; Cheng, Su-Chun ; Supko, Jeffrey G....
British Journal of Cancer. 126 (2021) 7 - p. 1027-1036 , 2021

Link: https://doi.org/10.1038/..